Impact Factor
1.98
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
0.56
80 total citations
h5-index
10
h5 depth signal
Cited share
26.6%
41 of 154
Total citations
80
Citation footprint
Metric signal
0.46
External metric anchor
Self-citation
6.3%
5 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United Kingdom
221
United States
38
Australia
23
New Zealand
5
Canada
4
Citing Fields of Research
Pharmacology & Toxicology
112
Cardiology
89
Allergies
84
Medical Ethics
71
Diabetes
70
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,772
Articles tracked across the journal lifetime
Indexed publication set
154
41 cited publications
Last 12 months
51
4.3 publications/month
Open access share
9.8%
5 OA publications in the last year
Leading citing country
United Kingdom
221 citing publications
Leading citing field
Pharmacology & Toxicology
112 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v3n18, Sept. 3, 1965-
v3n18, Sept. 3, 1965-
Active Coverage
Research Focus & Classification
Indexed Subjects
Allergies
Pharmacology & Toxicology
Patient Care
Cardiology
Digestive Disorders
Kidney Diseases
Viral Identification & Phylogenetics
Issuing & Sponsoring Bodies
Contributor
Consumers' Association
Broad Categories
Drug Therapy
Pharmacology
Allergies
Medical Ethics
Diabetes
Cardiology
Pharmacology & Toxicology
Patient Care
MeSH Descriptors
Drug Therapy
Pharmaceutical Preparations
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1136/dtb.2026.000020
Open DOI
Using genomics to personalise prescribing
02
DOI 10.1136/dtb.2026.000044
Open DOI
Recent updates from BNF—BNF 92
03
DOI 10.1136/dtb.2026.000047
Open DOI
Please look your patients in the eye, and listen
04
DOI 10.1136/dtb.2025.000052corr1
Open DOI
Correction: Review of levodopa inhalation powder (Inbrija) for Parkinson’s disease
05
DOI 10.1136/dtb.2026.000039
Open DOI
Precision medicine arrives in COPD
06
07
DOI 10.1136/dtb.2025.000038
Open DOI
Management of urogenital gonococcal infection
Gonorrhoea, caused by the bacterium Neisseria gonorrhoeae , is the second most common bacterial sexually transmitted infection diagnosed in the UK. Diagnoses remain highest among specific population groups: men who have sex with men, you...
08
DOI 10.1136/dtb.2026.000030
Open DOI
Discontinuation of levothyroxine in older adults
Overview of: Ravensberg J, Gussekloo J, Le Cessie S, et al . Discontinuation of levothyroxine in adults aged 60 years or older. JAMA 2026;335:1491-1498. doi:10.1001/jama.2026.2864
09
DOI 10.1136/dtb.2025.000052
Open DOI
Review of levodopa inhalation powder (Inbrija) for Parkinson’s disease
10
DOI 10.1136/dtb.2026.000019
Open DOI
Single National Formulary: solution or distraction?
Bibliographical & Catalog Notes
At head of title: DTB <Aug. 2001->.
Also issued online.
Indexes: Vols. 11-15, 1973-77 with v. 15; Vols. 14-16, 1976-78 with v. 16; Vols. 16-18, 1978-80 with v. 18; Vols. 17-19, 1979-81 with v. 19.
Supersedes: Medical letter (British edition).
Vol. 18, no. 3 (1980)19920824 Notice not published Printed on acid-free paper